Evidence map›Paper›PMID 42716546›Full record

SynthesisEuropean respiratory review : an official journal of the European Respiratory Society2026

Normal age-related decline in forced vital capacity: a systematic review and meta-analysis.

Imran Satia, Katlyn Brown, Jody Filkowski, Glenda Babe, Raymond Milan, Sean Tiggelaar, Martin Kolb

Abstract readSystematic ReviewMeta-Analysis
In one paragraph

Synthesis in European respiratory review : an official journal of the European Respiratory Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Imran SatiaFaculty of Health Sciences, McMaster University, Hamilton, ON, Canada satiai@mcmaster.ca.ORCID https://orcid.org/0000-0003-4206-6000
Katlyn BrownMedlior Health Outcomes Research Ltd., Calgary, AB, Canada.
Jody FilkowskiMedlior Health Outcomes Research Ltd., Calgary, AB, Canada.
Glenda BabeBoehringer Ingelheim Canada Ltd., Burlington, ON, Canada.
Raymond MilanBoehringer Ingelheim Canada Ltd., Burlington, ON, Canada.
Sean TiggelaarBoehringer Ingelheim Canada Ltd., Burlington, ON, Canada.
Martin KolbFaculty of Health Sciences, McMaster University, Hamilton, ON, Canada.ORCID https://orcid.org/0000-0003-3837-1467

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lung function peaks in early adulthood and declines thereafter, even without respiratory disease. Differentiating physiological ageing from pathological trajectories is critical for diagnosis, prognostication and interpretation of clinical trial end-points, particularly in interstitial lung diseases where attenuation of forced vital capacity (FVC) decline is a primary outcome in most trials. Without a benchmark for expected ageing, it is difficult to determine whether therapy preserves lung function by preventing FVC loss or mirrors natural trajectories. We conducted a systematic review and meta-analysis of longitudinal evidence on age-related FVC changes among adults without lung disease. A search of major databases and conference proceedings identified 7160 citations; 50 publications representing 35 cohorts and over 365 000 participants met eligibility criteria. Follow-up ranged from three to 35 years, with three to 12 spirometric assessments per participant. Over five decades of research, a consistent pattern of decline after early adulthood was evident, but estimates varied widely (10-80 mL·year

Indexed as

AgingHealthy AgingLungLung DiseasesAdultAgedAged, 80 and overAge FactorsFemaleHumansMaleMiddle AgedPredictive Value of TestsPrognosisSpirometryTime Factors

Identifiers

PMID42716546
PMCPMC13555310

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.